Challenges and Opportunities in Deploying ACT Antimalarials for Malaria Treatment
Author Information
Author(s): Christopher JM Whitty, Clare Chandler, Evelyn Ansah, Toby Leslie, Sarah G Staedke
Primary Institution: London School of Hygiene & Tropical Medicine
Hypothesis
How can the deployment of artemisinin combination therapy (ACT) be improved to ensure it reaches those who need it most?
Conclusion
The deployment of ACT antimalarials has the potential to significantly reduce malaria mortality, but current delivery systems are failing to reach the majority of those in need.
Supporting Evidence
- Most malaria-endemic countries have adopted ACT as their antimalarial drug policy.
- Many people who need antimalarials do not receive them due to financial and healthcare access barriers.
- A significant proportion of antimalarials are given to individuals who do not have malaria.
Takeaway
This study talks about how important it is to get the right malaria medicine to the right people, especially since many who need it don't get it, and some who get it don't actually have malaria.
Methodology
This review outlines current evidence, possible solutions, and research priorities regarding the deployment of ACT antimalarials.
Potential Biases
Potential biases may arise from the reliance on existing studies that may not represent all settings accurately.
Limitations
The review does not provide new empirical data but synthesizes existing literature and evidence.
Participant Demographics
The review discusses issues primarily in malaria-endemic countries in Africa and Asia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website